• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[脂质体吸入给药用于支气管哮喘中支气管溶解制剂的转运]

[The inhalation administration of liposomes for the transport of broncholytic preparations in bronchial asthma].

作者信息

Nevzorova V A, Luk'ianov P A, Protopopova M Iu, Gel'tser B I

出版信息

Vopr Kurortol Fizioter Lech Fiz Kult. 1996 Nov-Dec(6):12-4.

PMID:9103017
Abstract

Effectiveness of free and capsule phenoterol B2-agonist in experimental bronchial asthma has been assessed in vitro and in vivo in rats and rabbits using different liposomes: from egg lecithin, total phospholipids from pig or human lung. It was found that free phenoterol stabilizes mast cell (MC) condition, but has no antiinflammatory effect. Utilization of empty phospholipid vesicles brings both MC stabilization and decline of inflammation in the airways. In packing phenoterol in the liposomes antiinflammatory and membrane-stabilizing effects noticeably improved. It may be due to synergistic effects of the beta-agonist and phosphatidylcholine which is the base of liposome. The discussion covers mechanisms of high efficacy of homologous liposomes.

摘要

已在体外以及在大鼠和兔子体内使用不同脂质体(来自鸡蛋卵磷脂、猪或人肺的总磷脂)评估了游离型和胶囊型酚丙喘宁(β2-激动剂)在实验性支气管哮喘中的有效性。研究发现,游离酚丙喘宁可稳定肥大细胞(MC)状态,但无抗炎作用。使用空的磷脂囊泡可实现MC稳定以及气道炎症减轻。将酚丙喘宁包裹在脂质体中时,抗炎和膜稳定作用显著改善。这可能归因于β-激动剂与作为脂质体基础的磷脂酰胆碱的协同作用。讨论内容涉及同源脂质体高效性的机制。

相似文献

1
[The inhalation administration of liposomes for the transport of broncholytic preparations in bronchial asthma].[脂质体吸入给药用于支气管哮喘中支气管溶解制剂的转运]
Vopr Kurortol Fizioter Lech Fiz Kult. 1996 Nov-Dec(6):12-4.
2
Nitric oxide synthase in bronchial epithelium and nitric oxide metabolites in the lungs of rats with bronchial asthma after fenoterol inhalation.
Bull Exp Biol Med. 2000 Aug;130(8):763-5. doi: 10.1007/BF02766088.
3
Evidence based answers--is salmeterol safe in asthma?循证解答——沙美特罗用于哮喘是否安全?
Aust Fam Physician. 2006 Aug;35(8):625-6.
4
Beta-agonist therapy and asthma mortality in Japan.
Lancet. 1998 May 9;351(9113):1406-7. doi: 10.1016/S0140-6736(05)79446-0.
5
Bronchodilator resuscitation in the emergency department. Part 2 of 2: dosing strategies.急诊科支气管扩张剂复苏。第2部分,共2部分:给药策略。
Respir Care. 2000 May;45(5):497-512.
6
Inhaling beta(2)-agonist with heliox-driven in bronchial asthma.在支气管哮喘中使用氦氧混合气驱动吸入β2激动剂。
Chin Med J (Engl). 2003 Jul;116(7):1011-5.
7
Regularly scheduled versus as-needed use of inhaled beta agonists in the treatment of asthma.在哮喘治疗中,吸入型β受体激动剂的定期使用与按需使用对比。
Clin Pharm. 1992 Oct;11(10):877-9.
8
New developments in bronchodilator therapy.支气管扩张剂治疗的新进展
Curr Opin Pulm Med. 1996 Jan;2(1):35-9.
9
Why particle size should affect clinical response to inhaled therapy.为什么颗粒大小会影响吸入疗法的临床反应。
J Aerosol Med. 2001;14 Suppl 1:S27-34. doi: 10.1089/08942680150506312.
10
Indacaterol Novartis/skyePharma.茚达特罗 诺华/斯凯制药公司
Curr Opin Investig Drugs. 2006 May;7(5):457-63.